Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Diphtherinum is a homeopathic nosode prepared from the sterile lysate of the diphtheritic membrane or the toxin produced by *Corynebacterium diphtheriae*. In homeopathic practice, it is primarily indicated for the treatment of diphtheria, post-diphtheritic paralysis, and chronic throat conditions characterized by dark red, swollen tonsils and offensive breath. It is also used in homeoprophylaxis. Like other homeopathic remedies, its preparation involves serial dilution and succussion (potentization), often to potencies where no original molecules of the toxin remain. Its mechanism of action is based on the homeopathic principle of "like cures like" (similia similibus curentur), intended to stimulate a self-healing response, though it lacks a recognized pharmacological mechanism or molecular target in conventional medicine.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on diphtherinum.